DaVita HealthCare Partners Inc (DVA.N) Analysts | Reuters.com
Edition:
United States

DaVita HealthCare Partners Inc (DVA.N)

DVA.N on New York Stock Exchange

77.32USD
4:02pm EDT
Change (% chg)

$0.64 (+0.83%)
Prev Close
$76.68
Open
$76.85
Day's High
$77.33
Day's Low
$76.12
Volume
334,120
Avg. Vol
315,699
52-wk High
$81.89
52-wk Low
$61.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.04 December 30 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 4
(2) OUTPERFORM 0 0 0 0
(3) HOLD 7 7 7 7
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.31 2.31 2.31 2.42

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 10 3,764.21 3,890.77 3,694.60 3,690.10
Quarter Ending Dec-16 10 3,773.56 3,906.09 3,701.30 3,755.86
Year Ending Dec-16 13 14,789.70 15,304.70 14,554.70 14,491.60
Year Ending Dec-17 13 15,684.80 16,149.00 15,297.30 15,640.40
Earnings (per share)
Quarter Ending Sep-16 11 1.04 1.07 1.00 1.06
Quarter Ending Dec-16 11 1.01 1.09 0.93 1.09
Year Ending Dec-16 12 3.95 4.06 3.81 4.12
Year Ending Dec-17 13 4.40 4.70 4.12 4.67
LT Growth Rate (%) 2 13.65 15.00 12.30 13.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 3,505.93 3,581.14 75.20 2.15
Quarter Ending Dec-15 3,498.10 3,533.59 35.49 1.01
Quarter Ending Sep-15 3,457.16 3,525.67 68.50 1.98
Quarter Ending Jun-15 3,366.36 3,434.62 68.25 2.03
Quarter Ending Mar-15 3,249.19 3,287.97 38.77 1.19
Earnings (per share)
Quarter Ending Mar-16 0.86 0.92 0.06 7.43
Quarter Ending Dec-15 0.97 1.01 0.04 4.58
Quarter Ending Sep-15 0.96 1.00 0.04 3.63
Quarter Ending Jun-15 0.95 0.95 0.00 0.38
Quarter Ending Mar-15 0.86 0.86 0.00 0.44

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 3,764.21 3,764.21 3,764.21 3,730.73 3,690.10
Quarter Ending Dec-16 3,773.56 3,773.56 3,773.56 3,735.79 3,755.86
Year Ending Dec-16 14,789.70 14,789.70 14,791.90 14,618.00 14,491.60
Year Ending Dec-17 15,684.80 15,684.80 15,687.50 15,463.50 15,640.40
Earnings (per share)
Quarter Ending Sep-16 1.04 1.04 1.04 1.04 1.06
Quarter Ending Dec-16 1.01 1.01 1.01 1.02 1.09
Year Ending Dec-16 3.95 3.95 3.95 3.90 4.12
Year Ending Dec-17 4.40 4.40 4.40 4.36 4.67

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.